This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Sergey Tsukanov, Ph.D.
Senior Director Chemistry at Eli Lilly and Company
Speaker

Profile

Sergey Tsukanov is Senior Director in Synthetic Molecule Design and Development group at Eli Lilly and Company.

Sergey has studied chemistry at North Carolina State University. After obtaining his Ph.D. he conducted his postdoctoral training at Vanderbilt University and joined Eli Lilly in 2013 as a part of LIFA Innovation Fellowship program. For over ten years with Eli Lilly Sergey has supported CMC efforts across various Peptide and Oligonucleotide programs and in his current role Sergey is focused on late-stage development and commercialization activities for Oligonucleotide drug candidates.

Agenda Sessions

  • Enzymatic Ligation, Regulatory Challenges and Potential Platform Approaches

    16:45